Advertisement
YOU ARE HERE: LAT HomeCollectionsVascular Genetics Inc
IN THE NEWS

Vascular Genetics Inc

FEATURED ARTICLES
BUSINESS
September 14, 2002 | Bloomberg News
GenStar Therapeutics Corp. and closely held Vascular Genetics Inc. agreed to merge, becoming a biotechnology company focused on gene therapy. Shareholders of each San Diego firm will own 50% of the new company, to be named Autus Genetics Corp. Autus plans to focus on developing a gene therapy treatment for heart disease developed by Human Genome Sciences Inc. Human Genome, which owns a 27% stake in Vascular Genetics, will own 15% of the new company. Baxter International Inc.
ARTICLES BY DATE
Los Angeles Times Articles
|